• Skip to primary navigation
  • Skip to main content
AMRA MedicalAMRA Medical

AMRA Medical

Precision for Decision

  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Set Up
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Media
  • About Us
    • About AMRA
    • Our Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us

Industrifonden Invests SEK 10 Million in AMRA

January 27, 2015
  • Facebook
  • Twitter
  • LinkedIn
  • Mail

LINKÖPING, Sweden; January 27, 2015 – Industrifonden is investing an additional SEK 10 million in the Linköping, Sweden-based company, AMRA, which has developed a unique online analysis service for standardized measurement of fat and muscle mass in the body. This is critical in diagnosing various obesity-related diseases. The capital will be used to further expand the business.

Industrifonden made its first investment of SEK 5 million in Advanced MR Analytics AB (AMRA) one year ago, with the aim of investing more if the company developed as planned.

“In 2014, AMRA met all the targets we had set with our initial investment,” said Lars Henriksson, Investment Manager at Industrifonden. “Among other things, it has added its first paying customers: major research projects in five different universities around the world.”

“AMRA is well on its way to becoming the future standard for fat and muscle mass measurement, which will also change the way obesity, one of the world’s largest health problems, is viewed and treated,” he continued.

AMRA is developing a new method to measure exactly where and how much fat and muscles are in the body. This is done through an online analysis service that can interpret images from a magnetic camera. In this way, it will be possible to detect early on which individuals are at risk of diabetes and liver and muscle disorders in order to initiate medical treatment as soon as possible.

“Through Industrifonden’s continued investment in AMRA, we can increase the pace of our international expansion,” said Tommy Johansson, CEO of AMRA. “We are now opening an office in Norway and will then move on to the US.”

For more information, please contact

Lars Henriksson, Investment Manager, Industrifonden, tel. +46 70 210 90 38

Tommy Johansson, CEO of AMRA, tel. +46 708 964 850

All posts
  • Facebook
  • Twitter
  • LinkedIn
  • Mail
AMRA Medical
Follow us

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

  • Data Privacy Policy
  • Cookie Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support

Newsletter

© 2025 AMRA Medical AB
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}